Certara (NASDAQ:CERT – Get Rating) had its price objective lowered by equities research analysts at Barclays from $25.00 to $18.00 in a research report issued on Tuesday, The Fly reports. Barclays’s target price points to a potential upside of 6.57% from the company’s previous close.
Other research analysts have also recently issued reports about the stock. TheStreet cut shares of Certara from a “c-” rating to a “d+” rating in a report on Friday, June 16th. Morgan Stanley increased their price target on shares of Certara from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, March 10th. Stephens began coverage on shares of Certara in a report on Tuesday, April 11th. They set an “overweight” rating and a $28.00 price target on the stock. Finally, Credit Suisse Group increased their price target on shares of Certara from $22.00 to $27.00 in a report on Monday, March 27th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $23.38.
Certara Trading Down 3.5 %
NASDAQ:CERT opened at $16.89 on Tuesday. The company has a 50-day moving average price of $20.86 and a 200-day moving average price of $19.99. Certara has a 12 month low of $10.60 and a 12 month high of $24.96. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.27. The stock has a market cap of $2.70 billion, a price-to-earnings ratio of 187.67, a P/E/G ratio of 1.00 and a beta of 1.58.
Certara (NASDAQ:CERT – Get Rating) last issued its quarterly earnings results on Monday, May 8th. The company reported $0.12 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.12. The company had revenue of $90.30 million during the quarter, compared to analyst estimates of $91.29 million. Certara had a net margin of 4.03% and a return on equity of 5.53%. Certara’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same period last year, the business earned $0.11 EPS. Equities analysts predict that Certara will post 0.37 EPS for the current year.
Insider Buying and Selling
In related news, SVP Richard M. Traynor sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, April 14th. The shares were sold at an average price of $23.66, for a total value of $118,300.00. Following the sale, the senior vice president now owns 182,368 shares in the company, valued at $4,314,826.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Patrick F. Smith sold 19,104 shares of the firm’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $21.55, for a total transaction of $411,691.20. Following the sale, the insider now directly owns 59,975 shares in the company, valued at approximately $1,292,461.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Richard M. Traynor sold 5,000 shares of the firm’s stock in a transaction on Friday, April 14th. The shares were sold at an average price of $23.66, for a total transaction of $118,300.00. Following the sale, the senior vice president now owns 182,368 shares in the company, valued at $4,314,826.88. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,104 shares of company stock worth $634,091. 2.60% of the stock is owned by insiders.
Institutional Trading of Certara
Several institutional investors and hedge funds have recently modified their holdings of CERT. Harvest Fund Management Co. Ltd bought a new stake in shares of Certara during the 1st quarter valued at $37,000. OLD Mission Capital LLC bought a new stake in Certara in the 4th quarter valued at $49,000. HighMark Wealth Management LLC bought a new stake in Certara in the 1st quarter valued at $53,000. Advisors Asset Management Inc. increased its holdings in Certara by 121.1% in the 1st quarter. Advisors Asset Management Inc. now owns 3,108 shares of the company’s stock valued at $75,000 after acquiring an additional 1,702 shares during the last quarter. Finally, Wells Fargo & Company MN increased its holdings in Certara by 12.4% in the 4th quarter. Wells Fargo & Company MN now owns 5,325 shares of the company’s stock valued at $86,000 after acquiring an additional 586 shares during the last quarter. 67.34% of the stock is currently owned by institutional investors.
Certara Company Profile
Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.